Related Experiment Video
Updated: Jun 6, 2026

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
RNAi-mediated Rab5a suppression inhibits proliferation and migration of vascular smooth muscle cells
Zhigang Ma1, Hao Wang, Liang Wu
1General Surgery of Huashan Hospital, Ministry of Education, Shanghai Medical College, Fudan University, Shanghai, China.
Objective:
The migration and proliferation of vascular smooth muscle cells (VSMC) are early and crucial events in the pathogenesis of intimal hyperplasia, the primary cause of restenosis after vascular reconstruction. We tested the hypothesis that down-regulation of Rab5a, a prototypical member of the Rab family of GTPases, leads to inhibition ofVSMC proliferation and migration in the rat model.
Methods:
The intimal hyperplasia rat model was established and was used to test the expression of Rab5a at the vascular anastomoses at 7, 14 and 28 days post-operatively. The VSMCs were isolated from the thoracic aorta of SD rats and the expression of Rab5a was tested before and after exposure to RNAi by real-time PCR and Western blot.VSMC migration and proliferation were detected by flow cytometry using standard commercially available techniques and aTranswell chamber.
Results:
The rat models had significant stenosis at the anastomoses and the intima/media ratio was higher than that of the rat vessels. The expression of Rab5a was higher at the anastomotic site and peaked at 14 days after operation. The expression of Rab5a increased in the cultured VSMCs and decreased after RNAi. Proliferation and migration ofVSMCs had been inhibited by down-regulating the expression of Rab5a.
Conclusion:
Aberrant expression of Rab5a can be found after vascular reconstruction and the proliferation and migration ofVSMCs can be inhibited by RNAi silencing of Rab5a. This suggests the critical role for Rab5a in VSMCs proliferation and migration, and thus intimal hyperplasia and restenosis. Rab5a suppression might be a potential molecular therapeutic strategy to inhibit intimal hyperplasia.
Insights
Down-regulating Rab5a (a GTPase) inhibits vascular smooth muscle cell proliferation and migration, offering a potential strategy against intimal hyperplasia and restenosis after vascular reconstruction.
Area of Science:
- Vascular Biology
- Molecular Medicine
- Cellular Signaling
Background:
- Vascular smooth muscle cell (VSMC) migration and proliferation are key to intimal hyperplasia, a cause of restenosis.
- Rab5a, a GTPase, is implicated in cellular processes relevant to vascular disease.
Purpose of the Study:
- To investigate the role of Rab5a in VSMC proliferation and migration.
- To test if down-regulating Rab5a inhibits VSMC activity in a rat model of intimal hyperplasia.
Main Methods:
- Established a rat model of intimal hyperplasia.
- Quantified Rab5a expression in vivo and in cultured VSMCs using real-time PCR and Western blot.
- Assessed VSMC proliferation and migration via flow cytometry and Transwell assays, with and without RNA interference (RNAi) for Rab5a.
Main Results:
- Rat models showed significant anastomotic stenosis and increased intima/media ratio.
- Rab5a expression was elevated at anastomoses, peaking at 14 days post-operation.
- RNAi-mediated Rab5a down-regulation significantly inhibited VSMC proliferation and migration in vitro.
Conclusions:
- Aberrant Rab5a expression is associated with vascular reconstruction and intimal hyperplasia.
- Silencing Rab5a via RNAi effectively inhibits VSMC proliferation and migration.
- Rab5a plays a critical role in VSMC function, making its suppression a potential therapeutic target for restenosis.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
Abnormal Proliferation
Experimental RNAi
Cell Polarization by Rho Proteins

